ACIU241220C2500
- 0.00
- 0.000.00%
AC Immune Newsroom
Analysts Offer Insights on Healthcare Companies: Benitec Biopharma (BNTC), Bluebird Bio (BLUE) and AC Immune SA (ACIU)
H.C. Wainwright Maintains AC Immune(ACIU.US) With Buy Rating, Maintains Target Price $16
AC Immune Analyst Ratings
Promising Interim Data and Safety Profile Justify Buy Rating for AC Immune's ACI-7104.056 Vaccine Trial
AC Immune Analyst Ratings
H.C. Wainwright Maintains AC Immune(ACIU.US) With Buy Rating, Maintains Target Price $16
Optimistic Buy Rating on AC Immune Due to Promising Vaccine and Pipeline Developments
BTIG Maintains AC Immune(ACIU.US) With Buy Rating, Maintains Target Price $8
AC Immune Analyst Ratings
H.C. Wainwright Maintains AC Immune(ACIU.US) With Buy Rating, Maintains Target Price $16
Analyst Issues Buy Rating for AC Immune SA on Promising Alzheimer's Treatment Prospects
Analysts' Top Healthcare Picks: AC Immune SA (ACIU), Equillium (EQ)
Buy Rating on AC Immune SA for Promising Alzheimer's and Parkinson's Vaccines
BTIG Starts AC Immune With Buy Rating, $8 Price Target
AC Immune Analyst Ratings
Buy Rating Justified by Strategic Partnerships and Promising Pipeline in AC Immune SA
Buy Rating Affirmed: AC Immune's Promising Alzheimer's Vaccine and Strategic Takeda Partnership
Analysts Offer Insights on Healthcare Companies: Arcutis Biotherapeutics (ARQT), Fulcrum Therapeutics (FULC) and AC Immune SA (ACIU)
AC Immune Analyst Ratings
Buy Rating for AC Immune SA on Promising Alzheimer's Vaccine Trial Design and Potential Accelerated Approval